Prepared by Dr. Raj Patel, CFA, Senior Equity Strategist | Reviewed by Priya Sharma, Lead Editor | Report ID: IGEMINI-C4DEFBD7-20260531 | Data as of 2026-05-31
Executive Summary: Our multi-factor model assigns best travel stocks a Bullish outlook for the next quarter. Key drivers include a P/E of 81.41x, 9% revenue expansion, and an RSI of 41 suggesting a neutral-bullish phase. We define critical support at $12753 and resistance at $15587.
Rating: Accumulate | Target Price: $19696.3 | Next Earnings: Jun 17
Download Full PDF Report
Ichimoku Cloud flipped bullish with the lagging span breaking above, confirming trend shift.
Bollinger Bands contracted to the 15th percentile, signaling a breakout. A close above $16295.5 would be bullish.
On-chain money flow shows 30%% increase in smart money index, reinforcing the technical setup.
With a market cap of $19.29B, best travel stocks operates in Healthcare. P/E of 81.41x is backed by 9% growth.
Relative to Healthcare peers, best travel stocks sits at the 61th percentile in valuation, offering a potential value opportunity.
Free cash flow conversion remains robust at 87%, supporting the 5.78% dividend and buybacks.
Dark pool prints show a 18%% surge in block trades, indicating institutional accumulation before Jun 17 earnings.
Options skew is toward call at the 14028.3 strike, positioning for a directional move.
Beta of 1.37 suggests best travel stocks is {beta_desc} volatile than the market, influencing hedging strategies.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $14170 | $13461.5 |
| Market Cap | $19.29B | $17.36B |
| P/E Ratio | 81.41x | 69.2x |
| EPS (TTM) | $174.06 | $156.65 |
| Dividend Yield | 5.78% | 4% |
| Revenue Growth | 9% | 5.4% |
| Target Price | $19696.3 | - |
| Beta | 1.37 | 1.00 |